Walgreens Boots Alliance, Inc. (NASDAQ:W(BA)) declared a quarterly dividend on Friday, January 29th, Wall Street Journal reports. Shareholders of record on Friday, February 19th will be paid a dividend of 0.4675 per share by the pharmacy operator on Friday, March 12th. This represents a $1.87 dividend on an annualized basis and a yield of 3.72%. The ex-dividend date is Thursday, February 18th.
Walgreens Boots Alliance has increased its dividend payment by 19.4% over the last three years and has increased its dividend annually for the last 44 consecutive years.
Shares of Walgreens Boots Alliance stock traded down $0.43 during trading on Friday, reaching $50.25. The company’s stock had a trading volume of 10,476,909 shares, compared to its average volume of 8,578,785. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The business’s 50-day moving average price is $43.74 and its 200-day moving average price is $39.86. Walgreens Boots Alliance has a 52 week low of $33.36 and a 52 week high of $55.49. The firm has a market cap of $43.42 billion, a PE ratio of 100.50, a P/E/G ratio of 1.52 and a beta of 0.44.
Walgreens Boots Alliance (NASDAQ:W(BA)) last issued its quarterly earnings data on Wednesday, January 6th. The pharmacy operator reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.19. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The business had revenue of $36.31 billion during the quarter, compared to analysts’ expectations of $35.01 billion. During the same quarter in the previous year, the company earned $1.37 EPS. The business’s revenue was up 5.7% on a year-over-year basis. Equities analysts predict that Walgreens Boots Alliance will post 4.84 earnings per share for the current year.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total transaction of $207,750.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 16.91% of the company’s stock.
A number of brokerages recently issued reports on W(BA). Truist increased their price target on Walgreens Boots Alliance from $44.00 to $48.00 in a research report on Friday, January 8th. Truist Financial increased their target price on Walgreens Boots Alliance from $40.00 to $44.00 in a report on Tuesday, January 5th. Mizuho raised their price target on Walgreens Boots Alliance from $37.00 to $47.00 and gave the stock a “neutral” rating in a research report on Monday, January 11th. TheStreet cut shares of Walgreens Boots Alliance from a “b-” rating to a “c” rating in a research report on Thursday, January 7th. Finally, Barclays raised their target price on shares of Walgreens Boots Alliance from $40.00 to $47.00 and gave the company an “equal weight” rating in a report on Friday, January 8th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $44.50.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Story: Understanding Market Liquidity
(BA)” alt=”Dividend History for Walgreens Boots Alliance (NASDAQ:W(BA))” title=”Dividend History for Walgreens Boots Alliance (NASDAQ:W(BA))”/>
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
7 Marijuana Stocks Worth Speculating On
To say it’s been a rough two years for the cannabis industry is an understatement. Due to a combination of issues (including some self-inflicted wounds), the cannabis boom predicted in 2018 has not materialized. But that could be about to change.
If Joe Biden wins the presidential election, it will likely be part of a “Blue Wave” that will bring Democratic party control of both houses of Congress. And even if President Trump successfully wins a second term, it is still possible that Republicans could lose their hold on the Senate.
The bottom line is there is a range of outcomes that are possible. Most of those outcomes are favorable to the legalization of marijuana. And even if cannabis is not made legal on the federal level, it seems likely that the remaining states holding out will take steps to legalization. That’s because, like gambling, cannabis may create an economic lift that cash-strapped states may find too difficult to turn down.
One thing is certain. If you wait until the right time, you’ll have missed out on some eye-popping initial gains. But to get that reward in the future, you’ll need to assume some risk now. In this special presentation, we’ve identified seven cannabis stocks that you can consider when evaluating your opportunity in the cannabis sector.
View the “7 Marijuana Stocks Worth Speculating On “.
